Weishuo Li

535 total citations
10 papers, 435 citations indexed

About

Weishuo Li is a scholar working on Immunology, Oncology and Biomedical Engineering. According to data from OpenAlex, Weishuo Li has authored 10 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Oncology and 4 papers in Biomedical Engineering. Recurrent topics in Weishuo Li's work include CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and Immune cells in cancer (3 papers). Weishuo Li is often cited by papers focused on CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and Immune cells in cancer (3 papers). Weishuo Li collaborates with scholars based in China, Argentina and United States. Weishuo Li's co-authors include Can Zhang, Zhigui Su, Caoyun Ju, Lei Rong, Yong Zhang, Meixi Hao, Lingjing Xue, Kaiming Li, Yue Chen and Lulu Zhu and has published in prestigious journals such as Nano Letters, Biomaterials and Advanced Drug Delivery Reviews.

In The Last Decade

Weishuo Li

10 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weishuo Li China	7	224	197	154	98	76	10	435
Lujia Huang China	9	183 0.8×	150 0.8×	148 1.0×	87 0.9×	79 1.0×	14	400
Mark Prytyskach United States	9	169 0.8×	113 0.6×	207 1.3×	95 1.0×	102 1.3×	9	450
Erica N. Bozeman United States	13	161 0.7×	211 1.1×	209 1.4×	176 1.8×	121 1.6×	20	524
Changlong Wang China	7	159 0.7×	132 0.7×	167 1.1×	45 0.5×	73 1.0×	17	401
Xuemeng Guo China	12	242 1.1×	221 1.1×	218 1.4×	75 0.8×	73 1.0×	28	584
Lindsay Scheetz United States	9	221 1.0×	326 1.7×	248 1.6×	172 1.8×	123 1.6×	9	577
Yuchen Yan China	5	203 0.9×	208 1.1×	264 1.7×	98 1.0×	70 0.9×	9	507
Qi‐Song Tong China	10	198 0.9×	167 0.8×	111 0.7×	87 0.9×	107 1.4×	15	361
Dailin Xu China	7	290 1.3×	124 0.6×	177 1.1×	47 0.5×	141 1.9×	8	439
Xiuxiu Cong China	9	183 0.8×	113 0.6×	171 1.1×	67 0.7×	119 1.6×	19	411

Countries citing papers authored by Weishuo Li

Since Specialization

Citations

This map shows the geographic impact of Weishuo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weishuo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weishuo Li more than expected).

Fields of papers citing papers by Weishuo Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weishuo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weishuo Li. The network helps show where Weishuo Li may publish in the future.

Co-authorship network of co-authors of Weishuo Li

This figure shows the co-authorship network connecting the top 25 collaborators of Weishuo Li. A scholar is included among the top collaborators of Weishuo Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weishuo Li. Weishuo Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Hao, Meixi, Sijia Chen, Xiuqi Li, et al.. (2024). Spatiotemporally Controlled T‐Cell Combination Therapy for Solid Tumor. Advanced Science. 11(25). e2401100–e2401100. 2 indexed citations

2.

You, Yuchan, Feiyang Jin, Luwen Zhu, et al.. (2023). A photo-activable nano-agonist for the two-signal model of T cell in vivo activation. Journal of Controlled Release. 361. 681–693. 3 indexed citations

3.

Li, Weishuo, Meixi Hao, Yujiao Wang, et al.. (2022). An EPR-Independent extravasation Strategy: Deformable leukocytes as vehicles for improved solid tumor therapy. Advanced Drug Delivery Reviews. 187. 114380–114380. 11 indexed citations

4.

Li, Yanyi, Weishuo Li, Shijing Liu, et al.. (2021). Simultaneous blockage of contextual TGF-β by cyto-pharmaceuticals to suppress breast cancer metastasis. Journal of Controlled Release. 336. 40–53. 20 indexed citations

5.

Zhang, Ying, Cong Wang, Weishuo Li, et al.. (2021). Neutrophil Cyto‐Pharmaceuticals Suppressing Tumor Metastasis via Inhibiting Hypoxia‐Inducible Factor‐1α in Circulating Breast Cancer Cells. Advanced Healthcare Materials. 11(3). e2101761–e2101761. 22 indexed citations

6.

Hao, Meixi, Siyuan Hou, Weishuo Li, et al.. (2020). Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy. Science Translational Medicine. 12(571). 142 indexed citations

7.

Li, Weishuo, Zhigui Su, Meixi Hao, Caoyun Ju, & Can Zhang. (2020). Cytopharmaceuticals: An emerging paradigm for drug delivery. Journal of Controlled Release. 328. 313–324. 41 indexed citations

8.

Rong, Lei, et al.. (2019). Iron chelated melanin-like nanoparticles for tumor-associated macrophage repolarization and cancer therapy. Biomaterials. 225. 119515–119515. 140 indexed citations

9.

Qi, Jing, Weishuo Li, Kong-jun Lu, et al.. (2019). pH and Thermal Dual-Sensitive Nanoparticle-Mediated Synergistic Antitumor Effect of Immunotherapy and Microwave Thermotherapy. Nano Letters. 19(8). 4949–4959. 51 indexed citations

10.

Li, Weishuo. (2011). The Nutrients Analysis and Evaluation of Argopectens irradias. Acta Nutrimenta Sinica. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact